Here's the live share price of Gufic BioSciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Gufic BioSciences has gained 20.82% CAGR. Over the past year, the corresponding return has been -27.91%.
Gufic BioSciences’s current P/E of 58.25x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gufic BioSciences | -6.23 | -7.74 | -8.14 | -18.28 | -27.91 | 12.40 | 20.82 |
| Sun Pharmaceutical Industries | 0.52 | 0.17 | -3.01 | 3.70 | -0.07 | 19.19 | 22.11 |
| Divi's Laboratories | 2.14 | -3.19 | -5.49 | 0.39 | 5.44 | 30.15 | 10.65 |
| Torrent Pharmaceuticals | 8.00 | 6.24 | 10.81 | 17.47 | 41.29 | 41.20 | 26.71 |
| Cipla | 1.97 | -5.41 | -11.40 | -13.22 | -6.99 | 9.68 | 9.95 |
| Dr. Reddy's Laboratories | 2.12 | 6.83 | 1.81 | 0.65 | 5.99 | 11.75 | 6.11 |
| Lupin | 2.22 | 0.98 | 7.85 | 13.10 | 12.60 | 49.56 | 15.93 |
| Zydus Lifesciences | 2.49 | 2.94 | -3.60 | -7.97 | 0.93 | 24.39 | 14.29 |
| Mankind Pharma | 0.99 | -7.30 | -8.24 | -15.87 | -13.22 | 13.46 | 7.87 |
| Aurobindo Pharma | -0.60 | 0.32 | -3.10 | 9.34 | 4.80 | 35.81 | 4.90 |
| Alkem Laboratories | -3.68 | -6.06 | -4.35 | 2.43 | 17.66 | 18.54 | 13.66 |
| Biocon | 4.24 | 0.44 | -7.37 | 5.94 | 9.13 | 17.46 | -1.36 |
| Glenmark Pharmaceuticals | 4.89 | 0.87 | 6.92 | -0.74 | 53.55 | 67.80 | 32.83 |
| Abbott India | -3.74 | -5.55 | -9.83 | -20.72 | -5.42 | 9.08 | 12.77 |
| Laurus Labs | 6.36 | -7.33 | 1.33 | 17.66 | 85.00 | 45.09 | 22.35 |
| GlaxoSmithKline Pharmaceuticals | 4.38 | 8.43 | 4.71 | -6.28 | 28.59 | 27.72 | 12.61 |
| Anthem Biosciences | 5.33 | 10.52 | 1.36 | -16.68 | -5.78 | -1.97 | -1.18 |
| Ipca Laboratories | 5.83 | -0.58 | 0.86 | 10.19 | 3.11 | 21.19 | 9.71 |
| Ajanta Pharma | 2.63 | 8.17 | 16.03 | 9.12 | 14.42 | 33.69 | 19.43 |
| J B Chemicals & Pharmaceuticals | 6.65 | 4.19 | 8.18 | 15.12 | 18.43 | 26.10 | 26.01 |
Over the last one year, Gufic BioSciences has declined 27.91% compared to peers like Sun Pharmaceutical Industries (-0.07%), Divi's Laboratories (5.44%), Torrent Pharmaceuticals (41.29%). From a 5 year perspective, Gufic BioSciences has outperformed peers relative to Sun Pharmaceutical Industries (22.11%) and Divi's Laboratories (10.65%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 312.7 | 311.1 |
| 10 | 309.49 | 310.51 |
| 20 | 308.55 | 312.06 |
| 50 | 326.3 | 321.97 |
| 100 | 336.58 | 333.63 |
| 200 | 352.35 | 347.06 |
In the latest quarter, Gufic BioSciences remained same as its previous close in promoter holding, while DII stake increased to 3.74%, FII holding rose to 0.44%, and public shareholding moved down to 23.30% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 14,80,998 | 0.31 | 49.76 | |
| 10,00,000 | 0.84 | 33.6 | |
| 4,46,517 | 0.18 | 15 | |
| 3,53,689 | 0.61 | 11.88 | |
| 74,008 | 0.02 | 2.49 | |
| 39,197 | 0.04 | 1.32 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Feb 14, 2026, 4:09 AM IST | Gufic BioSciences - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Feb 14, 2026, 4:04 AM IST | Gufic BioSciences - Announcement under Regulation 30 (LODR)-Acquisition |
| Feb 14, 2026, 3:38 AM IST | Gufic BioSciences - Board Meeting Outcome for For Meeting Held On Friday, February 13, 2026 |
| Feb 11, 2026, 12:31 AM IST | Gufic BioSciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Feb 10, 2026, 12:17 AM IST | Gufic BioSciences - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Unaudited Financial Results (Stan |
Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 819.81 Cr. and Equity Capital is Rs. 10.03 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gufic BioSciences is ₹290.65 as on Feb 16, 2026.
The Gufic BioSciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Gufic BioSciences is ₹2,914.71 Cr as on Feb 16, 2026.
Today’s highest and lowest price of Gufic BioSciences are ₹304.45 and ₹284.10.
The 52-week high/low is the highest and lowest price at which Gufic BioSciences stock has traded in the past 52-week or nearly a year. The 52-week high of Gufic BioSciences is ₹419.65 and 52-week low of Gufic BioSciences is ₹285.00 as on Feb 16, 2026.
The Gufic BioSciences has shown returns of -5.53% over the past day, -7.74% for the past month, -8.14% over 3 months, -27.91% over 1 year, 12.4% across 3 years, and 20.82% over 5 years.
P/E ratio of and PB ratio of Gufic BioSciences are 58.25 and 4.62 on Feb 16, 2026. While the company gives a dividend yield of 0.03 per annum.